Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer

Clinical trial NCT07720167 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07720167
Sponsor: Medical University of South Carolina
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2026-11-01
Primary completion: 2029-11-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.